Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Targeted Pathway Inhibition in Patients With Pancreatic Cancer — Stella

Home/Locally Advanced Pancreatic Ductal Adenocarcinoma/Targeted Pathway Inhibition in Patients With Pancreatic Cancer

View on ClinicalTrials.gov

Recruiting

Back to Locally Advanced Pancreatic Ductal Adenocarcinoma trials

Targeted Pathway Inhibition in Patients With Pancreatic Cancer

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(1 site)

United States

OHSU Knight Cancer Institute, Portland, Oregon

Key details

Phase

Very early testing

Sponsor

OHSU Knight Cancer Institute

Collaborators

American Association for Cancer Research, Oregon Health and Science University

Enrollment target

~90 participants

Started

August 2019

Primary completion

June 2026

Age range

18 Years and older

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.